310 related articles for article (PubMed ID: 28947596)
1. Gut inflammation and dysbiosis in human motor neuron disease.
Rowin J; Xia Y; Jung B; Sun J
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947596
[TBL] [Abstract][Full Text] [Related]
2. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
4. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset.
Kim HS; Son J; Lee D; Tsai J; Wang D; Chocron ES; Jeong S; Kittrell P; Murchison CF; Kennedy RE; Tobon A; Jackson CE; Pickering AM
BMC Neurol; 2022 Feb; 22(1):62. PubMed ID: 35189854
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
6. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.
Figueroa-Romero C; Guo K; Murdock BJ; Paez-Colasante X; Bassis CM; Mikhail KA; Pawlowski KD; Evans MC; Taubman GF; McDermott AJ; O'Brien PD; Savelieff MG; Hur J; Feldman EL
Dis Model Mech; 2019 Nov; 13(2):. PubMed ID: 31597644
[TBL] [Abstract][Full Text] [Related]
7. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
8. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients.
Zeng Q; Shen J; Chen K; Zhou J; Liao Q; Lu K; Yuan J; Bi F
Sci Rep; 2020 Aug; 10(1):12998. PubMed ID: 32747678
[TBL] [Abstract][Full Text] [Related]
9. The fecal microbiome of ALS patients.
Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
[TBL] [Abstract][Full Text] [Related]
10. Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Blacher E; Bashiardes S; Shapiro H; Rothschild D; Mor U; Dori-Bachash M; Kleimeyer C; Moresi C; Harnik Y; Zur M; Zabari M; Brik RB; Kviatcovsky D; Zmora N; Cohen Y; Bar N; Levi I; Amar N; Mehlman T; Brandis A; Biton I; Kuperman Y; Tsoory M; Alfahel L; Harmelin A; Schwartz M; Israelson A; Arike L; Johansson MEV; Hansson GC; Gotkine M; Segal E; Elinav E
Nature; 2019 Aug; 572(7770):474-480. PubMed ID: 31330533
[TBL] [Abstract][Full Text] [Related]
11. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in ALS: possible role in pathogenesis?
McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
[No Abstract] [Full Text] [Related]
13. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice.
Wang H; Wang G; Banerjee N; Liang Y; Du X; Boor PJ; Hoffman KL; Khan MF
Front Immunol; 2021; 12():651191. PubMed ID: 33912174
[TBL] [Abstract][Full Text] [Related]
14. Intestine-Specific NHE3 Deletion in Adulthood Causes Microbial Dysbiosis.
Xue J; Dominguez Rieg JA; Thomas L; White JR; Rieg T
Front Cell Infect Microbiol; 2022; 12():896309. PubMed ID: 35719363
[TBL] [Abstract][Full Text] [Related]
15. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus.
Luo XM; Edwards MR; Mu Q; Yu Y; Vieson MD; Reilly CM; Ahmed SA; Bankole AA
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29196292
[TBL] [Abstract][Full Text] [Related]
17. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses.
Zhai CD; Zheng JJ; An BC; Huang HF; Tan ZC
Chin Med J (Engl); 2019 Aug; 132(15):1815-1822. PubMed ID: 31306225
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiome in sickle cell disease: Characterization and potential implications.
Brim H; Taylor J; Abbas M; Vilmenay K; Daremipouran M; Varma S; Lee E; Pace B; Song-Naba WL; Gupta K; Nekhai S; O'Neil P; Ashktorab H
PLoS One; 2021; 16(8):e0255956. PubMed ID: 34432825
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence.
Sun J; Huang T; Debelius JW; Fang F
J Intern Med; 2021 Oct; 290(4):758-788. PubMed ID: 34080741
[TBL] [Abstract][Full Text] [Related]
20. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
Lee A; Henderson R; Aylward J; McCombe P
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
